AI assistant
Sending…
Xylem Inc. — Director's Dealing 2013
Nov 4, 2013
30109_dirs_2013-11-04_fd93161a-77ef-449e-b4e8-b831d828c5f1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Xylem Inc. (XYL)
CIK: 0001524472
Period of Report: 2013-10-31
Reporting Person: Napolitano Kenneth (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-10-31 | Common Stock | M | 9975 | $21.0302 | Acquired | 63211 | Direct |
| 2013-10-31 | Common Stock | S | 9975 | $33.3939 | Disposed | 53236 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-10-31 | Employee Stock Options (Right to Buy) | $21.0302 | M | 9975 | Disposed | 2014-02-02 | Common Stock (9975) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3195.455 | Indirect |
Footnotes
F1: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $33.3901 to $33.3948 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
F2: As of October 31, 2013.
F3: These options are fully vested and exercisable.
More from Xylem Inc.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Mar 30
Director's Dealing
2026
Mar 3